Use our Project or Categories filter to narrow down your news search.

Reset

Fashion 4 Development Hosts the Third Annual Sustainable Goals Banquet

PAGE Magazine |
September 2023
Press

Fashion 4 Development (F4D) in partnership with Human Kind Institute hosted the Third Annual Sustainable Goals Banquet on Monday, September 18th during the 78th Session of the United Nations General Assembly (UNGA). The evening’s theme was ‘Healthier People, Healthier Planet.’ The night’s final award served as a tribute to the late Franca Sozzani, Editor in … Continued

G2P September Newsletter 2023

September 2023
G2P News

This newsletter highlights the International Conference on Newborn Sequencing (ICoNS) that is just around the corner on October 5-6, 2023 in London, UK. It’s not too late to register! Other G2P updates include media coverage of BabySeq1 publications, a new publication from the Sanford Imagenetics team about pharmacogenomics in primary care, and a blog post … Continued

Inside HGG Advances: A Chat with Nina Gold

American Society of Human Genetics |
September 2023
Press

Each month, the editors of Human Genetics and Genomics Advances interview an early-career researcher who has published work in the journal. This month they featured G2P collaborator Dr. Nina Gold to discuss her paper Phenotypes of undiagnosed adults with actionable OTC and GLA variants.

Genomic newborn screening: current concerns and challenges

The Lancet |
July 2023
Press

A recent editorial by The Lancet dives into the debate on universal newborn sequencing. While using genome sequencing as a screening tool for newborns has the potential to offer a great deal of relevant health information, there are certainly ethical issues and other challenges that also need to be addressed. The BabySeq Project is cited … Continued

G2P July Newsletter 2023

July 2023
G2P News

In this newsletter we’re excited to announce that the Precision Population Health initiative (PPH) is working with the South Central Foundation (SCF) on a new clinical genomic screening program to improve the health of the Alaska Native population. We are also thrilled to share that registration for the Second Annual International Conference on Newborn Sequencing … Continued

Precision screening for health equity

Medium |
June 2023
G2P Blog

“Addressing stark, deeply-rooted racial disparities in healthcare has to be a priority for medical research. PRS might be one tool to improve disease screening and move us beyond race-based medical decision-making and toward more equitable health outcomes.”

Next-generation screening – The promise and perils of DNA sequencing of newborns at birth

National Academies of Sciences, Engineering, and Medicine (NASEM) Workshop |
June 2023
Video

Newborn sequencing experts participated in a full-day workshop examining the utility of DNA sequencing in newborns. The workshop addressed the current state of newborn sequencing as well as relevant expected benefits, harms, and ethical considerations in six sessions. Robert C. Green, MD, MPH participated in a panel discussion and spoke about the BabySeq Project in … Continued

DNA sequencing in newborns reveals years of actionable findings for infants and families

Brigham and Women's Hospital |
June 2023
Press Release

“By screening apparently healthy newborns, entire families were alerted for the first time that dangerous but treatable genetic variants were present,” said corresponding author Robert C. Green, MD, MPH, a physician-scientist at Brigham and Women’s Hospital and professor of genetics at Harvard Medical School, who leads the BabySeq Project. “We were stunned to see that … Continued

The missing links: How to ensure omics data fulfills its promise

BioCentury |
May 2023
Press

“Omics data could herald a revolution in healthcare. The analysis of rich, interconnected and longitudinal multi-omics datasets promises a better understanding of the underlying biology of human health and disease, which in turn could lead to more effective prevention, earlier and more accurate diagnoses, new treatments and better choice of treatments. Despite that promise, only … Continued

A meaningful and personal career transition

Brigham Clinical & Research News |
May 2023
G2P News

Shaye Williams, G2P’s operation coordinator and diversity, equity, and inclusion lead, shares the story of her career transition into genomics research. After being introduced to genetic counseling as a prenatal patient, Shaye pursued an internship with G2P to learn more about the profession.

Your DNA can now be pulled from thin air. Privacy experts are worried.

New York Times |
May 2023
Press

“Anna Lewis, a Harvard researcher who studies the ethical, legal and social implications of genetics research, said that environmental DNA hadn’t been widely discussed by experts in bioethics. But after the findings from Dr. Duffy and his colleagues, it will be.”

Genetics experts support adding hundreds of treatable rare diseases to newborn screening

National Center for Advancing Translational Sciences |
May 2023
Press

“In a newly released study, nearly nine of 10 experts on rare diseases agreed that sequencing healthy newborns’ DNA to reveal treatable genetic disorders should be available for all infants. At least half of experts also endorsed testing for more than 400 genes as part of such newborn genomic screens. These NCATS-supported study results might … Continued

Should all U.S. newborns undergo genomic testing?

U.S. News & World Report |
May 2023
Press

“While newborns are only screened for about 60 treatable conditions, there are hundreds of genetic disorders that have targeted treatments. Now, a national survey of experts in rare diseases found the vast majority support DNA sequencing in healthy newborns…’It has been a longstanding dream to someday offer DNA sequencing to all newborns in order to … Continued

Rare disease experts support newborn genome sequencing

Inside Precision Medicine |
May 2023
Press

“Research led by Mass General Hospital for Children suggests that almost 90% of rare disease experts are in favor of newborn genome sequencing for monogenic treatable disorders…’Early identification of infants who are at risk for genetic disorders can be lifesaving and screening has the potential to improve healthcare disparities for affected children,’ said lead author … Continued

Rare-disease doctors support expanded newborn genomic screening, survey finds

STAT |
May 2023
Press

“When 238 rare-disease doctors across the U.S. were surveyed by a research team at Mass General Brigham in Boston, 88% of them agreed that DNA sequencing to screen for certain treatable childhood disorders should be made available to all newborns. The study was published Monday in JAMA Network Open.”

Mass General Brigham-led study finds experts support DNA sequencing in newborns

Mass General Brigham |
May 2023
Press Release

“Findings from a new study led by researchers at Mass General Brigham suggest that rare disease experts are now in favor of more expansive newborn testing. In a study published today in JAMA Network Open, 88 percent of rare disease experts agreed that DNA sequencing to screen for treatable childhood disorders should be made available … Continued

Five questions with Nic Encina: Working upstream or downstream

Ariadne Labs |
April 2023
G2P News

“In our Five-Question series, we highlight the staff and faculty behind the compelling work at Ariadne Labs. Upstream or downstream? That has long been a career question for Nic Encina, MS, MS, MBA, now Director of Strategy of the Precision Population Health initiative at Ariadne Labs.”

G2P featured in Brigham Clinical & Research News “Look who’s talking”

Brigham Clinical & Research News |
April 2023
Press

Genomes2People was featured in the latest issue of Brigham Clinical & Research News “Look who’s talking”. Past winners of the Brigham Research Institute’s BRIght Futures Prize share about the impact that the $100,0000 award has had on their work and careers. “In 2012, we were delighted to be the very first winners of the BRIght … Continued

G2P March Newsletter 2023

March 2023
G2P News

In this newsletter we’re excited to congratulate Sophia Adelson, Erin Drake, and Sheyenne Walmsley for winning the Brigham and Women’s Hospital Pillars of Excellence Awards. We’re also highlighting Carrie Zawatsky for her leadership in publishing NSGC’s first clinical practice resource on elective genetic testing, as well as Dr. Nina Gold’s NIH Mentored Clinical Scientist Research … Continued

Dr. Robert Green on the future of genetic testing

Beyond The Heart |
October 2022
Podcast

Robert C. Green, MD, MPH is Professor of Medicine (Genetics) at Harvard Medical School and a physician-scientist who directs the G2P Research Program at Brigham and Women’s Hospital, Broad Institute and Ariadne Labs. Dr. Green is internationally recognized for research and policy efforts accelerating the implementation of genomic/precision medicine. In this fascinating conversation Nieca and … Continued

Brigham Staff with President Robert S.D. Higgins

G2P staff recognized for the Brigham Way

Brigham Awards, Honors & Grants |
January 2023
G2P News, Press

Congratulations to G2P Genetic Counselor Janelle Shea and Operations Coordinator Shaye Williams for being nominated for and winning The Brigham Way Award, which recognizes employees who foster a culture of excellence, respect and professionalism by going above and beyond their duties to create an exceptional Brigham Experience for our patients and colleagues. Janelle celebrated her … Continued

G2P Newsletter November 2022

November 2022
G2P News

In this newsletter, we are excited to announce the date and location of the 2023 International Conference on Newborn Sequencing (ICoNS) happening the week of October 2nd-6th in London. Additionally, we highlight the professional accomplishments of our Senior Genetic Counselor/Project Manager Carrie Blout Zawatsky, as well as our team at the Annual National Society of … Continued

Head start: The promise of universal newborn sequencing

Illumina Genomics Forum |
September 2022
Video

The Illumina Genomics Forum is Illumina’s premier global event advancing the positive impact of genomic health. G2P Director Dr. Robert Green spoke alongside Ryan Taft on building the evidence base for offering comprehensive sequencing for every child at birth.

The path to universal newborn sequencing

International Conference on Newborn Sequencing (ICoNS) |
October 2022
Video

At the inaugural International Conference on Newborn Sequencing, researchers from eight studies across the world outlined their plans, goals, and results to date for their newborn sequencing initiatives. The BabySeq Project led by Robert Green at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School was the first randomized clinical trial designed to … Continued

From researcher to patient: Knowledge is power

Medium |
October 2022
G2P Blog

Last year, our former research assistant, Charlene Preys, underwent genetic counseling and testing for hereditary cancer associated with the ATM gene. Upon receiving her ATM status, Charlene’s risk of developing breast cancer jumped from 12 to 40%, and her risk of developing pancreatic cancer increased from <1% to 10%. Patient organizations and support groups were … Continued

Blood from a baby at birth can be gene sequenced to prevent diseases

USA TODAY |
October 2022
Press

“This week, Dr. Robert Green is hosting a conference in Boston, bringing together researchers and industry representatives from the U.S., U.K., European Union and Australia to set standards and discuss the challenges and opportunities presented by scaling up newborn genetic sequencing.”

Revealing the hidden impact of whole-genome sequencing for newborns

New Scientist |
August 2022
Press

“Would you have your baby’s genes sequenced at birth? A groundbreaking trial that used whole-genome sequencing to predict newborns’ future health, is starting to reveal the impact it has had on the whole family, seven years down the line.”